T65.5 Toxic effect of nitroglycerin and other nitric acids and esters

Name of the Condition

• Toxic Effect of Nitroglycerin and Other Nitric Acids and Esters

Summary

This condition describes adverse health effects resulting from exposure to nitroglycerin or other nitric acids and esters, which can cause systemic toxicity. These substances are known for their vasodilatory properties and may lead to hypotension, methemoglobinemia, or other metabolic disturbances when absorbed in excessive amounts.

Causes

The toxic effect is caused by exposure to nitroglycerin or related nitric acids and esters, which may occur through ingestion, inhalation, or dermal absorption. Common sources include pharmaceutical preparations (e.g., for angina), industrial chemicals, or accidental contact with contaminated materials. Overdose or improper handling can lead to poisoning.

Risk Factors

• Accidental or intentional overdose of nitroglycerin-containing medications.
• Occupational exposure in industries manufacturing or handling nitric acid esters.
• Prolonged or excessive use of topical nitroglycerin products.
• Lack of proper storage or labeling of nitroglycerin or related substances.

Symptoms

• Headache, dizziness, or lightheadedness due to vasodilation.
• Hypotension, tachycardia, or syncope.
• Nausea, vomiting, or abdominal pain.
• Methemoglobinemia, leading to cyanosis or dyspnea.
• In severe cases, seizures, coma, or respiratory failure.

Diagnosis

Diagnosis is based on clinical presentation, history of exposure, and laboratory tests. Blood tests may detect nitroglycerin levels or methemoglobinemia. Clinical assessment focuses on identifying signs of vasodilation, hypotension, or metabolic disturbances consistent with nitrate toxicity.

Treatment Options

Treatment involves supportive care, such as managing hypotension with fluids or vasopressors, and addressing methemoglobinemia with methylene blue if severe. Activated charcoal may be used if ingestion occurred recently. Monitoring for respiratory or cardiac complications is essential.

Prognosis and Follow-Up

Prognosis depends on the dose and duration of exposure. Most cases resolve with prompt treatment, but severe toxicity may lead to long-term complications. Follow-up includes monitoring for delayed effects and ensuring complete recovery before resuming normal activities.

Complications

• Persistent hypotension or shock.
• Severe methemoglobinemia requiring intensive care.
• Neurological damage from prolonged hypoxia.
• Cardiac arrhythmias or myocardial ischemia.

Lifestyle & Prevention

• Store nitroglycerin and related substances in secure, labeled containers.
• Follow dosing instructions carefully for pharmaceutical use.
• Use personal protective equipment when handling industrial chemicals.
• Educate patients on proper storage and disposal of medications.

When to Seek Professional Help

Seek immediate medical attention if symptoms of overdose occur, such as severe dizziness, fainting, or difficulty breathing. Contact emergency services for suspected poisoning or accidental exposure.

Tips for Medical Coders

Document the specific substance (nitroglycerin or other nitric acids/esters) and route of exposure (ingestion, inhalation, etc.) to support coding accuracy. Include details on clinical findings (e.g., methemoglobinemia) and treatment to clarify the toxic effect. Ensure the code T65.5 is used when the toxic effect is attributed to these substances.